
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $68.6M | -- | -- | $1.00 | -- |
07/25/2025 | Q2 | $67.2M | -- | -- | $0.97 | -- |
04/25/2025 | Q1 | $63.7M | $63.8M | $0.78 | $0.89 | -$0.11 |
01/24/2025 | Q4 | $63.1M | $63.6M | $0.94 | $0.90 | $0.04 |
10/25/2024 | Q3 | $61.3M | $61.2M | $0.91 | $0.88 | $0.03 |
07/25/2024 | Q2 | $60.7M | $68.7M | $0.87 | $0.85 | $0.02 |
04/25/2024 | Q1 | $60.2M | $60M | $0.91 | $0.86 | $0.05 |
01/25/2024 | Q4 | $59.8M | $65.8M | $1.16 | $0.89 | $0.27 |
10/25/2023 | Q3 | -- | -- | $0.98 | $0.90 | $0.08 |
07/21/2023 | Q2 | -- | -- | $0.57 | $0.91 | -$0.34 |
04/25/2023 | Q1 | -- | -- | $0.94 | $1.09 | -$0.15 |
01/25/2023 | Q4 | -- | -- | $1.01 | $1.13 | -$0.12 |
10/25/2022 | Q3 | -- | -- | $1.11 | $1.03 | $0.08 |
07/25/2022 | Q2 | -- | -- | $1.00 | -- | -- |
04/27/2022 | Q1 | -- | -- | $0.92 | -- | -- |
01/25/2022 | Q4 | -- | -- | $0.95 | -- | -- |
10/25/2021 | Q3 | -- | -- | $0.94 | -- | -- |
07/26/2021 | Q2 | -- | -- | $0.95 | -- | -- |
04/26/2021 | Q1 | -- | -- | $0.90 | -- | -- |
01/25/2021 | Q4 | -- | -- | $0.97 | -- | -- |
10/26/2020 | Q3 | -- | -- | $0.89 | -- | -- |
07/27/2020 | Q2 | -- | -- | $0.77 | -- | -- |
04/27/2020 | Q1 | -- | -- | $0.67 | -- | -- |
01/27/2020 | Q4 | -- | -- | $0.86 | -- | -- |
10/25/2019 | Q3 | -- | -- | $0.83 | -- | -- |
07/25/2019 | Q2 | -- | -- | $0.85 | -- | -- |
04/25/2019 | Q1 | -- | -- | $0.84 | -- | -- |
01/25/2019 | Q4 | -- | -- | $0.83 | -- | -- |
10/25/2018 | Q3 | -- | -- | $0.80 | -- | -- |
08/03/2018 | Q2 | -- | -- | $0.78 | -- | -- |
04/25/2018 | Q1 | -- | -- | $0.71 | -- | -- |
01/25/2018 | Q4 | -- | -- | $0.45 | -- | -- |
10/25/2017 | Q3 | -- | -- | $0.62 | -- | -- |
07/25/2017 | Q2 | -- | -- | $0.60 | -- | -- |
04/25/2017 | Q1 | -- | -- | $0.57 | -- | -- |
01/25/2017 | Q4 | -- | -- | $0.53 | -- | -- |
10/25/2016 | Q3 | -- | -- | $0.53 | -- | -- |
07/25/2016 | Q2 | -- | -- | $0.50 | -- | -- |
04/25/2016 | Q1 | -- | -- | $0.48 | -- | -- |
01/25/2016 | Q4 | -- | -- | $0.49 | -- | -- |
10/26/2015 | Q3 | -- | -- | $0.46 | -- | -- |
Lakeland Financial reported $63.8M worth of top line sales in its most recent quarter.
Lakeland Financial announced earnings per share of $0.78 which represents a miss of analyst forecast a $0.89 per share.
Lakeland Financial reported -- that represents -- per share over the last quarter.
Lakeland Financial's earnings are forecast to grow from $3.63 per share to $3.42 per share next year representing an increase of 3.86%.
Lakeland Financial's next earnings date is July 25, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.